Unknown

Dataset Information

0

Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.


ABSTRACT:

Purpose

Repeatability of baseline FDG-PET/CT measurements has not been tested in ovarian cancer. This dual-center, prospective study assessed variation in tumor 2[18F]fluoro-2-deoxy-D-glucose (FDG) uptake, tumor diameter, and tumor volume from sequential FDG-PET/CT and contrast-enhanced computed tomography (CECT) in patients with recurrent platinum-sensitive ovarian cancer.

Experimental design

Patients underwent two pretreatment baseline FDG-PET/CT (n = 21) and CECT (n = 20) at two clinical sites with different PET/CT instruments. Patients were included if they had at least one target lesion in the abdomen with a standardized uptake value (SUV) maximum (SUVmax) of ≥ 2.5 and a long axis diameter of ≥ 15 mm. Two independent reading methods were used to evaluate repeatability of tumor diameter and SUV uptake: on site and at an imaging clinical research organization (CRO). Tumor volume reads were only performed by CRO. In each reading set, target lesions were independently measured on sequential imaging.

Results

Median time between FDG-PET/CT was two days (range 1-7). For site reads, concordance correlation coefficients (CCC) for SUVmean, SUVmax, and tumor diameter were 0.95, 0.94, and 0.99, respectively. Repeatability coefficients were 16.3%, 17.3%, and 8.8% for SUVmean, SUVmax, and tumor diameter, respectively. Similar results were observed for CRO reads. Tumor volume CCC was 0.99 with a repeatability coefficient of 28.1%.

Conclusions

There was excellent test-retest repeatability for FDG-PET/CT quantitative measurements across two sites and two independent reading methods. Cutoff values for determining change in SUVmean, SUVmax, and tumor volume establish limits to determine metabolic and/or volumetric response to treatment in platinum-sensitive relapsed ovarian cancer.

SUBMITTER: Rockall AG 

PROVIDER: S-EPMC5152730 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.

Rockall Andrea G AG   Avril Norbert N   Lam Raymond R   Iannone Robert R   Mozley P David PD   Parkinson Christine C   Bergstrom Donald D   Sala Evis E   Sarker Shah-Jalal SJ   McNeish Iain A IA   Brenton James D JD  

Clinical cancer research : an official journal of the American Association for Cancer Research 20140226 10


<h4>Purpose</h4>Repeatability of baseline FDG-PET/CT measurements has not been tested in ovarian cancer. This dual-center, prospective study assessed variation in tumor 2[18F]fluoro-2-deoxy-D-glucose (FDG) uptake, tumor diameter, and tumor volume from sequential FDG-PET/CT and contrast-enhanced computed tomography (CECT) in patients with recurrent platinum-sensitive ovarian cancer.<h4>Experimental design</h4>Patients underwent two pretreatment baseline FDG-PET/CT (n = 21) and CECT (n = 20) at tw  ...[more]

Similar Datasets

| S-EPMC6367490 | biostudies-literature
| S-EPMC7612596 | biostudies-literature
| S-EPMC8833034 | biostudies-literature
| S-EPMC5459477 | biostudies-literature
| S-EPMC6681694 | biostudies-literature
| S-EPMC7456167 | biostudies-literature
| S-EPMC5628433 | biostudies-literature
| S-EPMC6787711 | biostudies-literature
| S-EPMC7908760 | biostudies-literature
| S-EPMC5526620 | biostudies-literature